Yoon-Sim Yap

17PUBLICATIONS
82CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesClinical midwiferyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Dec 17, 2025
Comprehensive benchmarking of methods for mutation calling in circulating tumor DNA.

Hanaé Carrié, Ngak Leng Sim, Pui Mun Wong

|Aug 22, 2024
A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer.

Emi Noguchi, Takashi Yamanaka, Hirofumi Mukai

|May 21, 2024
Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer.

Yen-Shen Lu, Eznal Izwadi Bin Mohd Mahidin, Hamdy Azim

|Nov 08, 2023
Intrinsic Subtype and Overall Survival of Patients with Advanced HR+/HER2- Breast Cancer Treated with Ribociclib and ET: Correlative Analysis of MONALEESA-2, -3, -7.

Aleix Prat, Nadia Solovieff, Fabrice André

|Sep 08, 2023
Emerging systemic therapy options beyond CDK4/6 inhibitors for hormone receptor-positive HER2-negative advanced breast cancer.

Jun Ma, Jack Junjie Chan, Ching Han Toh

|Aug 14, 2023
Potential value of ctDNA monitoring in metastatic HR + /HER2 - breast cancer: longitudinal ctDNA analysis in the phase Ib MONALEESASIA trial.

Joanne Chiu, Fei Su, Mukta Joshi

Pageof 3

Frequent Collaborators

3 joint publications

Jack Junjie Chan

2 joint publications

Yen-Shen Lu

2 joint publications

Anders Skanderup

1 joint publications

Yi Heng Seow